AGIO | Agios Pharmaceuticals, Inc. Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	937.11 Million	1.23 Billion	1.43 Billion	852.95 Million	890.74 Million	858.45 Million
Total Current Assets	833.83 Million	832.77 Million	1.06 Billion	636.67 Million	611.7 Million	613.78 Million
Cash And Short Term Investments	776.92 Million	1.09 Billion	1.28 Billion	670.53 Million	564.87 Million	805.42 Million
Cash and Cash Equivalents	88.2 Million	139.25 Million	203.12 Million	127.43 Million	80.93 Million	805.42 Million
Short Term Investments	688.72 Million	643.86 Million	816.89 Million	445.49 Million	483.94 Million	514.8 Million
Net Receivables	2.81 Million	2.2 Million	4.37 Million	25.39 Million	15.31 Million	10.44 Million
Inventory	19.07 Million	8.49 Million	16.19 Million	14.69 Million	7.33 Million	869 Thousand
Other Current Assets	35.02 Million	38.95 Million	11.81 Million	-73.95 Million	24.17 Million	17.16 Million
Total Non-Current Assets	103.28 Million	405.94 Million	373.5 Million	216.27 Million	279.03 Million	244.67 Million
Net PPE	69.79 Million	88.11 Million	104.23 Million	117.54 Million	126.1 Million	24.32 Million
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	29.43 Million	313.87 Million	266.37 Million	97.6 Million	152.92 Million	220.11 Million
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	4.05 Million	3.95 Million	2.9 Million	1.12 Million	-279.03 Million	238 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	126.09 Million	137.9 Million	145.76 Million	453.45 Million	250.21 Million	170.92 Million
Total Current Liabilities	67.95 Million	62.62 Million	59.82 Million	94.39 Million	92.88 Million	93.5 Million
Account Payables	9.78 Million	18.61 Million	16.7 Million	26.84 Million	21.89 Million	17.88 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	15 Million	13.66 Million	11.15 Million	7.41 Million	6.91 Million	-59.8 Million
Deferred Revenue	-	-	-	-	10.93 Million	92.51 Million
Other Current Liabilities	43.16 Million	30.35 Million	31.96 Million	60.14 Million	53.14 Million	42.91 Million
Total Non Current Liabilities	58.14 Million	75.27 Million	85.93 Million	359.05 Million	157.32 Million	77.41 Million
Long-Term Debt	56.98 Million	71.99 Million	85.93 Million	97.78 Million	106.74 Million	-
Deferred Revenue Non Current	-	-	-	261.26 Million	50.58 Million	59.8 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.15 Million	3.27 Million	-	261.26 Million	50.58 Million	17.6 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	811.01 Million	1.1 Billion	1.29 Billion	399.5 Million	640.52 Million	687.53 Million
Stock Holders Equity	811.01 Million	1.1 Billion	1.29 Billion	399.5 Million	640.52 Million	687.53 Million
Common Stock	72 Thousand	71 Thousand	71 Thousand	69 Thousand	68 Thousand	58 Thousand
Retained Earnings	-822.64 Million	-470.56 Million	-238.76 Million	-1.84 Billion	-1.51 Billion	-1.1 Billion
Accumulated other comprehensive income	-441 Thousand	-12.53 Million	-1.19 Million	105 Thousand	202 Thousand	-2.17 Million
Common Stock Equity	811.01 Million	1.1 Billion	1.29 Billion	399.5 Million	640.52 Million	687.53 Million
Capital Lease Obligation	56.98 Million	85.65 Million	97.09 Million	105.19 Million	113.66 Million	-
Total Investments	718.15 Million	957.73 Million	1.08 Billion	543.1 Million	636.87 Million	734.91 Million
Total Debt	71.99 Million	85.65 Million	97.09 Million	105.19 Million	113.66 Million	-
Net Debt	-16.2 Million	-53.6 Million	-106.03 Million	-22.23 Million	32.73 Million	-805.42 Million

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3
Total Assets	1.79 Billion	773.06 Million	849.7 Million	937.11 Million	937.11 Million	1 Billion
Total Current Assets	1.07 Billion	632.12 Million	663.62 Million	833.83 Million	833.83 Million	704.35 Million
Cash And Short Term Investments	1 Billion	569.89 Million	597.99 Million	776.92 Million	776.92 Million	872.39 Million
Cash and Cash Equivalents	253.73 Million	84.51 Million	118.76 Million	88.2 Million	88.2 Million	64.33 Million
Short Term Investments	751.02 Million	485.37 Million	479.22 Million	688.72 Million	688.72 Million	583.15 Million
Net Receivables	3.11 Million	3.76 Million	3.45 Million	2.81 Million	2.81 Million	1.17 Million
Inventory	26.42 Million	23.93 Million	23.07 Million	19.07 Million	19.07 Million	17.27 Million
Other Current Assets	39.88 Million	34.53 Million	39.11 Million	35.02 Million	35.02 Million	38.41 Million
Total Non-Current Assets	717.6 Million	140.93 Million	186.08 Million	103.28 Million	103.28 Million	302.9 Million
Net PPE	57.66 Million	61.47 Million	65.72 Million	69.79 Million	69.79 Million	73.94 Million
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	655.88 Million	75.4 Million	116.3 Million	29.43 Million	29.43 Million	224.9 Million
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	4.05 Million	4.05 Million	4.05 Million	4.05 Million	4.05 Million	4.05 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	165.12 Million	112.55 Million	105.78 Million	126.09 Million	126.09 Million	120.41 Million
Total Current Liabilities	119.45 Million	62.63 Million	51.69 Million	67.95 Million	67.95 Million	58.42 Million
Account Payables	17.14 Million	10.03 Million	11.15 Million	9.78 Million	9.78 Million	13.27 Million
Tax Payables	52.68 Million	-	-	-	-	-
Short Term Debt	16.31 Million	15.86 Million	15.4 Million	15 Million	15 Million	14.66 Million
Deferred Revenue	52.68 Million	-	-	-	-	-
Other Current Liabilities	33.3 Million	36.74 Million	25.12 Million	43.16 Million	43.16 Million	30.49 Million
Total Non Current Liabilities	45.67 Million	49.91 Million	54.09 Million	58.14 Million	58.14 Million	61.99 Million
Long-Term Debt	44.51 Million	48.76 Million	52.94 Million	56.98 Million	56.98 Million	60.83 Million
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.15 Million	1.15 Million	1.15 Million	1.15 Million	1.15 Million	1.15 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	1.62 Billion	660.51 Million	743.92 Million	811.01 Million	811.01 Million	886.84 Million
Stock Holders Equity	1.62 Billion	660.51 Million	743.92 Million	811.01 Million	811.01 Million	886.84 Million
Common Stock	73 Thousand	73 Thousand	73 Thousand	72 Thousand	72 Thousand	72 Thousand
Retained Earnings	-52.4 Million	-1 Billion	-904.19 Million	-822.64 Million	-822.64 Million	-726.7 Million
Accumulated other comprehensive income	3.42 Million	-1.04 Million	-1.08 Million	-441 Thousand	-441 Thousand	-5.89 Million
Common Stock Equity	1.62 Billion	660.51 Million	743.92 Million	811.01 Million	811.01 Million	886.84 Million
Capital Lease Obligation	60.83 Million	48.76 Million	52.94 Million	56.98 Million	56.98 Million	75.49 Million
Total Investments	751.02 Million	560.77 Million	595.52 Million	718.15 Million	718.15 Million	583.15 Million
Total Debt	60.83 Million	64.62 Million	68.34 Million	71.99 Million	71.99 Million	75.49 Million
Net Debt	-192.89 Million	-19.89 Million	-50.41 Million	-16.2 Million	-16.2 Million	11.16 Million

Balance Sheet Charts

Clene Inc.

CLNN

Full Analysis

Annual Balance Sheets
Lodestar Battery Metals Corp.

LSTR

Full Analysis

Annual Balance Sheets
Tenet Healthcare Corporation

THC

Full Analysis

Annual Balance Sheets
THC Biomed Intl Ltd.

THCBF

Full Analysis

Annual Balance Sheets
Freedom Holdings, Inc.

FHLD

Full Analysis

Annual Balance Sheets
UIL Finance Limited

UTLH

Full Analysis

Annual Balance Sheets

Global Stocks Search

Agios Pharmaceuticals, Inc. (AGIO)

Annual Balance Sheets

Balance Sheet Charts

Clene Inc.

Lodestar Battery Metals Corp.

Tenet Healthcare Corporation

THC Biomed Intl Ltd.

Freedom Holdings, Inc.

UIL Finance Limited